Effects of aripiprazole once-monthly on symptoms of schizophrenia in patients switched from oral antipsychotics.

about

Effects of aripiprazole once-monthly on symptoms of schizophrenia in patients switched from oral antipsychotics.

Item

http://www.wikidata.org/entity/Q47958975

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Effects of aripiprazole once-m ...... ched from oral antipsychotics.

@en

Effects of aripiprazole once-m ...... ched from oral antipsychotics.

@nl

type

Item

label

Effects of aripiprazole once-m ...... ched from oral antipsychotics.

@en

Effects of aripiprazole once-m ...... ched from oral antipsychotics.

@nl

prefLabel

Effects of aripiprazole once-m ...... ched from oral antipsychotics.

@en

Effects of aripiprazole once-m ...... ched from oral antipsychotics.

@nl

P1476

Effects of aripiprazole once-m ...... ched from oral antipsychotics.

@en

P2093

Anna Eramo

http://www.w3.org/2001/XMLSchema#string

Brian R Johnson

http://www.w3.org/2001/XMLSchema#string

Cathy Zhao

http://www.w3.org/2001/XMLSchema#string

Pamela P Perry

http://www.w3.org/2001/XMLSchema#string

Phyllis M Salzman

http://www.w3.org/2001/XMLSchema#string

Raymond Sanchez

http://www.w3.org/2001/XMLSchema#string

Robert D McQuade

http://www.w3.org/2001/XMLSchema#string

Timothy Peters-Strickland

http://www.w3.org/2001/XMLSchema#string

P2860

The positive and negative syndrome scale (PANSS) for schizophrenia

The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009.

Long-acting paliperidone palmitate - interim results of an observational study of its effect on hospitalization.

A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects.

Long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis of mirror-image studies.

Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia.

Hospitalization rates in patients switched from oral anti-psychotics to aripiprazole once-monthly: final efficacy analysis

Hospitalisation rates in patients switched from oral anti-psychotics to aripiprazole once-monthly for the management of schizophrenia.

Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials.

P304

460-465

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/S1092852916000365

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27531181

http://www.w3.org/2001/XMLSchema#string

P921

schizophrenia